Metformin-Xr Teva

Metformin Hydrochloride, the active ingredient in Metformin‑Xr Teva, is a biguanide presented as an oral tablet for oral administration. It helps lower elevated blood glucose levels by improving insulin sensitivity and decreasing hepatic glucose production, and is indicated for adult patients with type 2 diabetes mellitus.

GNH USA supplies Metformin‑Xr Teva as a licensed, Good Distribution Practice‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide under regulated quality standards. The company ensures batch‑to‑batch consistency and supports import documentation for global markets.

Metformin‑Xr Teva, a biguanide antidiabetic, is used to manage hyperglycemia in type 2 diabetes and related metabolic conditions.

- Type 2 diabetes mellitus: lowers fasting and postprandial glucose levels. - Prediabetes: helps delay progression to type 2 diabetes. - Polycystic ovary syndrome: improves insulin resistance and may aid menstrual regularity.

Metformin‑Xr Teva may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or dyspepsia. - Diarrhea: loose stools occurring especially after dose initiation. - Metallic taste: transient alteration in taste perception. - Loss of appetite: reduced desire to eat.

Serious or Rare Side Effects: - Lactic acidosis: a rare but potentially fatal accumulation of lactate. - Vitamin B12 deficiency: may develop with long‑term therapy. - Severe hypoglycemia: usually when combined with other glucose‑lowering agents. - Hepatic dysfunction: abnormal liver enzymes or hepatitis. - Skin rash: including severe cutaneous reactions. - Pancreatitis: inflammation of the pancreas.

Metformin‑Xr Teva requires careful patient assessment and monitoring to minimise risks.

- Renal function: evaluate creatinine clearance before starting and periodically thereafter. - Hepatic disease: avoid in patients with significant liver impairment. - Cardiovascular status: use cautiously in unstable heart failure. - Alcohol consumption: limit intake to reduce lactic acidosis risk. - Vitamin B12 monitoring: check levels during long‑term therapy. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Metformin‑Xr Teva can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure. - Cimetidine: can increase metformin plasma concentrations. - Alcohol: heightens risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and electrolytes.